SCHEDULE: AIGH Capital Management Divests SCPHARMACEUTICALS Stake
Beneficial Ownership Amendment
AIGH Capital Management LLC and Orin Hirschman have reported a complete divestment of their beneficial ownership in SCPHARMACEUTICALS INC., now holding 0% of common stock.
Summary
- Reporting Persons, including Orin Hirschman and AIGH Capital Management LLC, have filed an Amendment No. 4 to Schedule 13G.
- The filing indicates that as of September 30, 2025, the Reporting Persons beneficially own 0 shares of SCPHARMACEUTICALS INC. common stock.
- This represents 0% of the class of securities.
- All voting and dispositive powers (sole and shared) are reported as 0.
- The filing certifies that the securities were acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as it is a factual report of a complete divestment by an investor. It doesn't provide positive or negative operational news for the issuer, but a major investor exiting could be interpreted negatively by some.
Future Outlook
NA
Management Comments
- We certify that, to the best of our knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.
Industry Context
This filing is a standard disclosure of a change in beneficial ownership by an institutional investor and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: May interpret the complete divestment by AIGH Capital Management as a lack of confidence in SCPHARMACEUTICALS INC., potentially influencing the stock price.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring filing of this statement, indicating Reporting Persons' beneficial ownership became 0%. |
| 11/10/2025 | Signature date of the Schedule 13G Amendment No. 4. |
Keywords
SCPHARMACEUTICALS, AIGH Capital Management, Orin Hirschman, Schedule 13G, beneficial ownership, divestment, common stock, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.